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Abstract
Publically funded biobanking initiatives and genetic research should contribute towards reducing inequalities
in health by reducing the prevalence and burden of disease. It is essential that Maori and other Indigenous
populations share in health gains derived from these activities. The Health Research Council of New Zealand
has funded a research project (2012-2015) to identify Maori perspectives on biobanking and genetic research,
and to develop cultural guidelines for ethical biobanking and genetic research involving biospecimens. This
review describes relevant values and ethics embedded in Maori indigenous knowledge, and how they may be
applied to culturally safe interactions between biobanks, researchers, individual participants, and
communities. Key issues of ownership, privacy, and consent are also considered within the legal and policy
context that guides biobanking and genetic research practices within New Zealand. Areas of concern are
highlighted and recommendations of international relevance are provided. To develop a productive
environment for "next-generation" biobanking and genomic research,"‘next-generation" regulatory solutions
will be required.
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Engaging Māori  in Biobanking and Genetic  Research:  Legal ,  Ethical ,  and Policy 
Challenges  
Research involving human biospecimens and genetic data analysed in conjunction with personal or 
health information is becoming increasingly important for the understanding of complex diseases, 
and associated applications for their prevention, diagnosis, and treatment.  There is consensus in the 
scientific community that further progress will depend on access to larger numbers of biospecimens.   
As a result, there have been moves in New Zealand and elsewhere towards harmonization of 
biobanks (Du Plessis, 2007; Maschke, 2005).  Most commonly this involves the adoption of 
evidence-based standards for the collection, storage, and handling of biospecimens. However, the 
ability to establish and harmonise biobanks will depend in part on participants’ willingness to 
contribute. 
It is essential that Māori and other Indigenous populations share in health gains derived from 
biobanking and genetic research.  This review describes relevant values and ethics embedded in 
Māori indigenous knowledge, and how they may be applied to culturally safe interactions between 
Māori communities, participants, biobanks, and researchers.  Key issues of ownership, privacy, and 
consent are also considered within the legal and policy context that guides biobanking and genetic 
research practices within New Zealand.   
There are a number of formal (and informal) biobanks currently operating in New Zealand1 that 
provide researchers with necessary access to specimens for ethically approved research.  These 
entities tend to have well-established governance procedures that serve to protect participants’ 
interests, including the requirement that all proposed research seeking access to biospecimens and 
relevant data be reviewed by a human research ethics committee.  Formal biobanks generally have 
clear and transparent processes for the access to and use of samples in their collections; however, 
there are also numerous collections of samples held by research groups who conduct studies that 
may obtain consent for the future use of the samples.  These samples are available for future research 
and, while the samples can only be used for ethically approved studies, the processes for access to 
and use of the samples are often less clear. 
Biobanks provide researchers with access to biospecimens usually directly linked to clinical and 
other personal information.  This function immediately attracts questions of ownership of the 
biospecimens and derived data, consent of the donor, the extent to which the donor can share in the 
results, and privacy and ethics, particularly when the material is derived from vulnerable populations.  
The issues of appropriate governance and donor rights thus become vitally important.  It is not clear 
that existing regulatory solutions will meet the governance challenges presented by “next-
generation” biobanking and genetic research involving extensive networks of collaborating 
institutions and large international data sets (Fullerton, Anderson, Guzauskas, Freeman, & Fryer-
Edwards, 2010). 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
1 Examples are Middlemore Tissue Bank (Auckland), Cancer Society Tissue Bank (Christchurch), New 
Zealand Rare Diseases Biobank (Dunedin), The New Zealand Neurological Foundation Human Brain Bank 
(Auckland), and Melanoma Tissue Bank (Dunedin). 
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Māori  Perspectives  
Tikanga Māori refers to culturally grounded processes and practices that draw on the values and 
ethics embedded in matauranga Māori (Indigenous knowledge).  For Māori, the issues of ownership, 
privacy, and consent can be informed by tikanga Māori (Hudson, 2004a).  Similarly, tikanga can also 
inform the research process by ensuring culturally safe interactions with participants and 
communities (Jones, Crengle, & McCreanor, 2006).  From a traditional Māori perspective, the 
concepts that most closely relate to ownership are concerned with control over access and use of a 
resource.  The resource, for instance tissue, is recognised as a taonga2 protected by kaitiaki 
(guardians) who mediate the relationships between that resource and people.  To maintain the 
mauri (life force) of that resource (Marsden, 2003), Māori developed customs to ensure that the 
resource would be available to the next generation (taonga tuku iho).   The value of human tissue in 
a traditional context is reflected in the tikanga (correct practice) applied to activities involved with 
healing (Jones, 2000; Mark & Lyons, 2010) or death (Barlow, 1991; Nikora, Marsters, & Te 
Awekotuku, 2012), including pure/tohi (positive spiritual intervention), mākutu (negative spiritual 
intervention), tangi (funeral process), and hāhu (process of interring bones).  Tikanga were 
developed to moderate the potential use and misuse of human tissue and limit the risks for people, 
their whānau, and their communities (Roberts, 2005).  While the nature of potential uses and 
misuses has changed in contemporary times, the basic recognition of human tissue as a taonga, 
belonging to both the person and their communities, remains (Cram, Pihama, & Barbara, 2000).  All 
are relevant to understanding why Māori prioritise a duty of kaitiakitanga or “obligated stewardship” 
(Ministry for the Environment, 2002). 
For Māori, the notion of privacy is complicated by a value system that prioritises collective good 
over individual autonomy.  Traditionally, most healing would be done in a community setting so 
that community members would be aware of the issue and contribute to its solution (Port, Arnold, 
Kerr, Glavish, & Winship, 2008).  In this regard, the privacy of health information restricts the ability 
of the extended family and wider community to fulfil this function (Hudson, 2004b).  Nevertheless, 
the concept of restricting access to sensitive, or potentially dangerous, knowledge was known to 
traditional communities.  Tohunga (experts) were the stewards of information that was considered 
inherently special or personally sensitive, which they retained on behalf of the collective (Boulton, 
Hudson, Ahuriri-Driscoll, & Stewart, 2014).    
Similarly, the interrelationship between individuals and family or kin groups also affects the manner 
in which consent is constructed.  The importance of community support and engagement in 
construction of research has been argued for theoretical (e.g., Kaupapa Māori, community based 
participatory research) (Pihama, Cram, & Walker, 2002; Smith, 1998) and functional (integrated 
knowledge translation) (Canadian Institutes of Health Research [CIHR], 2012) reasons.  This type 
of engagement addresses issues relating to the safety of the study for the community (Hudson, 
2004b) and forms the cornerstone of establishing a “collective” consent for the project (Hudson, 
2009; Hutchings, 2009).  The concept of collective consent is complementary to an individual 
consent as it indicates community support for a study within which an individual can consent to 
participate (Hudson, 2004b).  Similarly, collective decision-making, where significant others (family, 
authority figures) support an individual to make decisions about participation, also contributes to 
how Māori consent to genetic research (Hutchings, 2009; Tupara, 2012).   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
2 The term “tissue” generally applies to a group of cells that perform a specific function. For Māori, it is 
suggested that tissue, as a discreet component of the tinana (body), has always been a taonga (treasure).  
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Identifying a Māori view on biobanking and genetic research is challenging as there are a number of 
views and perspectives evident across this community (Cram et al., 2000; Te Momo, 2007).  As with 
all new technologies, there is limited opportunity for Māori to critique or explore the risks and 
opportunities.  However, when given the space to consider how their interests are related to specific 
contexts (Cram, Phillips, Tipene-Matua, Parsons, & Taupo, 2004; Hutchings & Reynolds, 2007), 
Māori have demonstrated the ability to identify and conceptualise Māori values (Tupara, 2012) and 
to adapt relevant tikanga to these new situations (Hudson, Roberts, Smith, Tiakiwai, & Hemi, 2012).   
Genetic engineering and modification is inconsistent with tikanga Māori in that it seeks to change 
whakapapa (genealogy or the ways by which people come into relationship with the world, people, 
and life).  This, in turn, will disturb the mauri and balance of the individual and the community 
(Cram et al., 2000).  Nonetheless, in the health context (Roberts & Fairweather, 2004), some Māori 
do give support to the notion of genetic research (Hudson, Ahuriri-Driscoll, Lea, & Lea, 2007; 
Tawhara, 2005; Tipene-Matua, 2006), genomic research (Ahuriri-Driscoll et al., 2007), and 
biobanking (Tipene-Matua, 2006). 
Tikanga has been adapted in a number of hospitals for dealing with tissue in clinical settings 
(Auckland District Health Board, 2003) and research laboratories (Cheung, Gibbons, Dragunow, & 
Faull, 2007; Hudson, Allan, Bedford, Buckleton, & Stuart, 2008).  In these settings, the integration 
of tikanga Māori, such as the use of karakia (prayers), cleansing with wai (water), and the eating of 
kai (food), within standard processes provides a level of cultural safety for both the whanau (family) 
and the researcher/clinician (Cheung, 2011).  Tikanga also provide guidance around appropriate 
restrictions of use, access for families, and methods of disposal (Auckland District Health Board, 
2003).  These applications provide a foundation for identifying issues of significance that are likely 
to have relevance for genetic research and biobanking. 
Tikanga Māori is flexible (Hemara, 2006).  If we consider that some Māori actively participate 
within the area of genetic research, this would lend support for the use of tikanga concepts (Mead, 
2003).  Taonga, kaitiaki, and rangatiratanga (the right to exercise authority, autonomy, self-
determination, self-management, and ownership) are primary considerations when reflecting on the 
relationship between tikanga Māori, tissue, and using tikanga concepts, and implications for Māori 
of tissue use in the context of genetic research and biobanking (Cheung, 2011).  The obligation of 
kaitiaki to ensure the viability of taonga (in this case, tissue) would suggest that a meaningful 
governance role is required within the employment of a biobank (Ministry of Health, 2014; Health 
(Cervical Screening (Kaitiaki)) Regulations, 1995).  The concept of rangatiratanga would then 
support the rights of Māori to make decisions over their taonga and ensure that the mauri (essence, 
vitality) of the taonga remains strong (Tupara, 2012).  If an approach that recognizes tikanga Māori 
is taken, then processes that set standards of behaviour such as governance, regulation, and ethics 
will need to be consistent with principles of taonga, kaitiaki, mauri, mana (control), and 
rangatiratanga.   
The development of culturally grounded processes for biobanking and genomic research would have 
to consider how Māori principles and values are operationalised alongside existing principles, a 
process which is likely to highlight normative, epistemic, or preference differences (Hope, Molster, 
& O’Leary, 2009).    
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Biobanking and Genetic  Research:  Relevant New Zealand Legislation 
In New Zealand, the Health Act (1956), Human Tissue Act (2008), Health and Disability 
Commissioner Act (1994), Guidelines on the Use of Human Tissue for Future Unspecified 
Research Purposes (Ministry of Health, 2007), Code of Health and Disability Services Consumers’ 
Rights, the Privacy Act (1993), and the Health Information Privacy Code (1994) and regulations, 
provide the relevant legislative framework for researchers and biobanking.  However, a recent Law 
Commission Report observed that this current legislative framework is not very coherent and 
requires review (Office of the Privacy Commissioner, 2013).   
Internationally, the emergence of consortia conducting collaborative genetic population research 
involving large-scale data sharing has highlighted a number of challenges for governance, and 
inadequacies and conflicts between this existing legislation and research ethics, policy, and practices.  
In New Zealand and more widely, this is particularly evident in the context of ownership, privacy, 
and consent as these principles are commonly considered by researchers in relation to the individual 
rather than to a population or a community. 
Biobanks and issues of  privacy.  The New Zealand Bill of Rights Act (1990) does not provide 
an express right to privacy.  However, the Privacy Act (1993) does contain regulations applicable to 
health information.  The relevant regulation, the Health Information Privacy Code (1993), was 
issued in as a regulation under the Privacy Act (1993) and is administered by the Privacy 
Commissioner.  Ultimately, if there is a breach of the specific privacy principles, a complaint can be 
made to the Privacy Commissioner and the Human Rights Review Tribunal. 
The Health Information Privacy Code regulates how health agencies collect, hold, use, and disclose 
health information about identifiable individuals.  There are two key concepts in the code.  First, the 
purpose: Agencies must know why they are collecting health information and collect only the 
information they need.  Once health information has been collected from a patient for a particular 
purpose, it can be used or disclosed for that purpose without additional consent.  Second, openness: 
Agencies need to inform patients how their information is going to be used and disclosed so the 
patients can make decisions about whether to provide it.  The Health Information Privacy Code 
contains various rules relating to the purpose of collection of health information, source of health 
information, collection of health information from an individual, manner of collection of health 
information, correction of health information, storage and security of health information, access to 
personal health information, retention of health information, limits on use of health information, 
sufficient safeguard against potentially controversial research, and limits on the disclosure of health 
information and unique identifiers. 
These rules came into force before the emergence of large-scale biobanks, and the applicability and 
fit of these privacy rules to biobanking and protecting health information is at best tenuous.  Areas of 
concern include the lack of discretion between basic and research health information, the current 
limits on the use of health information, the discretion of biobanks to disclose information to third 
parties, and the restriction on the use of unique identifiers (Lee, 2012).  The interplay between 
various documents and mechanisms, such as the Guidelines on the Use of Human Tissue for Future 
Unspecified Research Purposes (Ministry of Health, 2007) and the Code of Health and Disability 
Services Consumers’ Rights that seek to protect health information may provide added protection 
for donors, other than that set out in the Health Information Privacy Code (1993).   
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Biobanks and issues of  ownership.   Internationally, it is not uncommon for the ownership of 
stored specimens to be a matter of litigation (Moore v. Regents of the University of California, 
1990), and various efforts to clarify the ownership of physical samples and custodial rights within a 
legislative framework have been pursued.  In 2008, Iceland promulgated legislative provisions3 (Act 
on Health Sector Database, 1998) to capture the ownership of physical samples stored by biobanks.  
Ownership was retained by the donors whilst the custodial rights were vested in the Icelandic 
government.  The legislation provided for the establishment of a database to store the present, past, 
and future health information of the Icelandic population.  This database encompassed a separate 
bank to store DNA and another to store genealogical information.   
The intention was that this super biobank would provide a research tool for the entire population of 
Iceland.  However, when a single license was granted to a commercial operator and subsequent court 
cases (Gudmundsdottir R v. The State of Iceland, 2003) highlighted the movement away from 
informed consent, the automatic inclusion of participants, and no right of family members to opt out 
on behalf of deceased family members (Lee, 2012), the Icelandic super biobank failed (Palsson, 
2008).  For similar reasons, biobanks in Tonga and Estonia, where the ownership was to be vested in 
the government with legislation providing protections to the donors, also failed.  The UK Biobank is 
the first successful DNA biobank and is subject to the oversight of an Independent Ethics and 
Governance Council that adheres to the comprehensive UK Biobank Ethics and Governance 
Framework (UK Biobank, 2007). 
There are a number of biobanks in New Zealand that store a variety of human tissue and samples.  
These are relatively small scale and held by clinicians and research groups for the purpose of 
researching a particular disease.  Although New Zealand has yet to establish a legal framework that 
adequately addresses issues of ownership for biobank samples, a raft of legislation, regulations, and 
codes collectively apply to biobanking and privacy, and also to consent and ownership issues.   
Biobanks and issues of  consent.    In New Zealand, the Code of Health and Disability Services 
Consumers’ Rights (Health and Disability Commissioner Act, 1994) provides that no health care 
procedure shall be performed without informed consent.  Rights 54, 65, and 76 of the Code reflect the 
elements of informed consent.  A biobank provides a service to promote health together with 
protecting health and preventing disease for populations over an extended timeframe and, in these 
terms, can be classified as a health care provider for the purposes of the Code and the Rights that 
relate to informed consent.   
Whether or not a biobank complies with the Code of Health and Disability Services Consumers’ 
Rights regarding informed consent is complex, primarily because the nature of the research can be 
difficult to determine and foresee, and the elements that form the basis of the informed consent are 
also complex and not universally agreed upon.  If the biobank takes all reasonable steps to give effect 
and comply with the Code of Health and Disability Services Consumers’ Rights then this effectively 
provides an escape clause7 when it is not possible to obtain informed consent without compromising 
the scientific value of the biobank (Caulfield, 2007).  In this regard, Mongoven and Solomon (2012) 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
3 On December 17, 1998 the Health Sector Database Act was passed. 
4 Right to Effective Communication. 
5 Right to be Fully Informed. 
6 Right to Make an Informed Choice and Give Informed Consent. 
7 Clause 3 of the Code. 
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suggest donors are not really “informed” since the specific goals, risks, and benefits of future research 
are not known at the time of tissue donation.  Further, since decisions regarding the specific use of 
samples ultimately will be made by the biobank, donors are not really providing “consent.”  
Ethical  Oversight  of  Research in New Zealand 
The Guidelines on the Use of Human Tissue for Future Unspecified Research Purposes issued by 
the Ministry of Health is intended to provide guidance for ethics committees when considering 
applications involving human tissue research (Lee, 2012).  These guidelines sit below the Statement 
of Procedures for Ethics Committees (previously the Operational Standards for Ethics Committees) 
and guide the Health and Disability Ethics Committees when considering applications for research.8 
This combined guidance is flexible and creates a standard that is amenable to future research.  
However, compliance with the guidelines does not always result in ethics approval because the 
ethical review process considers the balance of potential benefits from the research against the 
potential risks to the participant or donor.   
Together, the Code of Health and Disability Services Consumers’ Rights and the Statement of 
Procedures support biobanking and the use of human tissue for unspecified research.  However, the 
absence of any legislative framework to directly address the range of issues noted above means that 
the Health and Disability Ethics Committees do not have the degree of clarity to enable them to deal 
consistently and robustly with research involving the use of tissue from established biobanks. 
This broad concern is compounded by the changes to the Health and Disability Ethics Committee 
(HDEC) structure and process introduced in July 2012 after a government assessment of the 2010 
report from the Health Select Committee (Health Select Committee, 2011), who were investigating 
the means to potentially expand the number of clinical trials in New Zealand.  The resulting changes 
included: a reduction in the number of committees from seven to four, a reduction in the number of 
members from twelve to eight, the development of new Statements of Procedure (SOP) to replace 
the previous Operational Standard, a loss of responsibility for peer review, the removal of the 
requirement for student research less than doctoral standard to have ethical review, and the 
introduction of an online application system.  More important has been the introduction of the 35-
day clock, which is aimed at speeding up the review process, but with the potential that adherence to 
this requirement becomes the prime focus in the work of committees.  SOPs provide procedural 
guidance only and are intended to be read in conjunction with two other guideline documents 
published by the National Ethics Advisory Committee: Ethics Guidelines for Observational Studies; 
and the Ethics Guidelines for Intervention Studies, both of which were revised in 2012 to align them 
with the new HDEC structure (National Ethics Advisory Commitee, 2012a, 2012b).   
Of more serious concern in the context of biobanking and genetic research is the requirement for 
HDECs to focus their attention on the ethics and not the science of research application.  This 
ignores the fact that, commonly, the most serious ethical matters arise from the way in which 
proposed methodologies are applied in practice.   The interaction among the research question, the 
process of data collection, and method of analysis is directly related to the outcomes the study 
produces.  As Māori and Indigenous communities are particularly interested in cultural protocols for 
data and tissue collection as well as the outcomes and potential benefits of the project, the research 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
8 See section 11 of the New Zealand Health and Disability Act 2000, which contains provisions for the 
Minister of Health to establish an Ethics Committee and terms of reference. 
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methods need to be rigorously scrutinised (Hudson, Milne, Reynolds, Russell, & Smith, 2010).   A 
second concern is the sense that, in the latest iteration of the HDECs, issues of relevance to Māori 
are being “dropped off the agenda.”  This is primarily because the matter of Māori membership is not 
explicitly defined even though the Ministry of Health’s (informal) view is that this element of 
membership is still considered to be an important dimension in the composition of ethics 
committees.  In summary, these changes have resulted in the perception that the degree of 
protection afforded research participants by the ethics review process is now not as robust as it once 
was (Gillett & Douglass, 2012).  A manifestation of this perception is that key organisations in health, 
such as District Health Boards (DHBs), are setting up parallel structures (such as Māori Research 
Review committees) as a way of reducing this “risk quotient” to the organisation while drawing 
attention away from the risk associated with being a participant or donor.   
In summary, the environment of ethical oversight has become more structurally complex and the 
current HDEC system has been somewhat disempowered.  This makes it critical that issues around 
the relationships between Māori and the agencies involved in genetic research and biobanking are 
clarified through the development of cohesive guidelines that protect Māori interests and marry 
these with the goals of the health researcher community.        
Engagement with Māori  in the Ethics  Review Process 
The perspective held by many Māori, especially those involved in health research and including 
those who sit as Māori members on ethics committees, is that engagement with Māori should be a 
requirement except in very specifically defined circumstances.  However, the view that instances of 
non-consultation should be rare is one that provokes a range of reactions within the health research 
community at large.  The negative reaction to this tenet is generally couched in terms of criticism of 
the added cost and time arising from the supposed difficulty of finding suitable parties with whom to 
consult and then having to wait for responses that are said to be slow in coming.  The extent of the 
general relevance of this process is also questioned.  One possible solution is that consultation would 
only be required as a part of the ethics approval process when the research is clearly “Māori centred.”  
Alternatively, if research participants are recruited from the general population, then an ethics 
committee could be asked to deal with this category of research on paper much as is the practice now. 
This perspective is a long way from the opinion regarding Te Tiriti o Waitangi (“the Treaty”) 
responsibilities that softening the requirements for Māori consultation should be the exception and 
never the rule (Treaty of Waitangi, 1840).  Such a position is derived from the view that, in terms of 
the Treaty, all health research will be of relevance to Māori.  Whilst approaches described in 
applications to HDECs lie somewhere between these two stances, the annual reports from these 
committees express concern about the way researchers deal with Māori consultation and cultural 
matters generally, which suggests that HDECs tend to favour a more broadly defined consultation 
requirement.  Comments such as “some researchers pay no more than lip service to the cultural 
requirements” confirm a degree of dissatisfaction with the status quo (Northern Y Health and 
Disability Ethics Committee, 2008, p. 17).  Moreover, a related argument also points to the concern 
that any relaxation of the requirement to consult with Māori may potentially reduce the amount of 
research activity focused on Māori issues, particularly in the area of personal and population health. 
Moreover, the current system is not consistent in the way it deals with issues pertaining to Māori, 
and because there is an absence of nationally sanctioned guidelines (notwithstanding the utility of 
Te Ara Tika) ethics committees have been left to improvise in dealing with matters of relevance to 
Māori.  This situation may lend itself toward a focus on cultural dimensions while ignoring critical 
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issues such as impact on Māori and the reduction of health inequalities.  The modus operandi 
regarding Treaty responsibilities has not been observed to have changed over the past decade but, 
more importantly, has been made possibly worse in the latest iteration of the ethics review system.  A 
statement which describes this approach can be found in the Annual Report of the Multi-region 
Ethics Committee (2006) where it is suggested that: 
More often than not where consultation has occurred, it is framed around the need for 
cultural sensitivity and understanding with much less energy given to exploring the possible 
paradigmatic and research issues relating to Māori that may be implicated in the project.  
While matters of culture are important in the research process, there is a need for greater 
thought to be given to conceptual issues and questions, along with the shape of research 
outputs, if the results from health research are to contribute more positively to the health 
status of Māori.  (p. 8) 
Currently, researchers are required to outline: (a) how their study might benefit Māori; (b) what the 
main cultural issues are that Māori may face if they participate in the study; and (c) whether they 
have read the Health Research Council’s Guidelines for Researchers on Health Research Involving 
Māori (which contains Te Ara Tika as an appendix).  Unfortunately, the responses to these 
questions, and how a study might impact health inequality, historically and consistently have been 
answered poorly.  The uni-dimensional focus along with the uneven stance taken by the current 
ethics committees in respect to these questions does not augur well for the creating of ethics review 
processes that keep Māori participants safe in the context of genetic research and biobanking. 
Engagement with Māori  Through Research Partnerships 
A recent comprehensive international review and comparative analysis of Indigenous research 
guidelines in New Zealand, Australia, Canada, and the United States (US) identified a number of 
areas of concern and a need for further work in developing research policy that promotes respectful 
engagement with Indigenous communities (Taniguchi, Taualii, & Maddock, 2012).  In New 
Zealand, Australia, and the US, there is currently no direction to seek community engagement 
during the development of research protocols as there is in Canada, although all countries did 
provide some guidance in other areas of community consultation (Taniguchi et al., 2012).  And 
unlike Canada’s Tri-Council Policy Statement: Ethical Conduct for Research Involving Humans 
(Canadian Institutes for Health Research, National Sciences and Engineering Research Council of 
Canada, and Social Sciences and Humanities Research Council of Canada, 2010), New Zealand’s 
Guidelines for Researchers on Health Research Involving Māori (Health Research Council New 
Zealand, 2008), does not provide guidance on the use and storage of biological materials, 
prioritization of research uses, or post-research obligations (other than community review of study 
findings before release).   
More specifically, New Zealand research guidelines do not stipulate a requirement to define 
potential uses prior to sample collection, to make provision for individual or community withdrawal 
of samples, to discuss secondary uses with contributing individuals or communities, or to obtain 
community approval for secondary uses of material or the resulting genetic data (Taniguchi et al., 
2012), although researchers may opt to do so.  Furthermore, there is no direction around 
prioritization of research uses such that the research should benefit the contributing population, or a 
requirement that a clear position on commercial applications be disclosed.   
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Thus there is much to learn from the experiences of Indigenous people in other countries.  The 
National Congress of American Indians (NCAI) Policy Research Center (PRC) has made an 
important commitment to education through the provision of specific resources that address unique 
considerations in conducting research with American Indian and Alaska Native (AI/AN) 
communities.  Toolkits are freely available to communities and individuals who may have questions 
about genetic research including frequently asked questions; common concerns regarding 
stigmatization, data sharing, and strategies for addressing these concerns; and sample consent forms 
and research agreements for tribal communities (National Congress of American Indians, 2014a).  
Information is also available to researchers who have questions about how to effectively partner with 
AI/AN communities covering information about Indigenous knowledge, ethics, research policies, 
and protocols, and negotiation of research relationships with communities (National Congress of 
American Indians, 2014b). 
In Canada, tribal governments have the legal authority to regulate research that is conducted on 
their lands and with their citizens (Deloria, 2003) and tribes as a result have employed a variety of 
research review processes (Sahota, 2007).  These range from the involvement of Tribal Councils to 
the establishment of tribal research review boards and/or partnerships with others to review 
protocols that are presented to the community.  If an AI/AN community does develop formal 
guidelines for research that is undertaken with their tribal members, researchers may be required to 
provide a written commitment to abide by these policies.  Penalties may also be applied if 
researchers conduct unapproved research or violate other agreed terms for conducting research 
(Sahota, 2007).  This is not currently the case in New Zealand.    
Engagement with Māori  in the Policy Development Process 
In terms of satisfying Crown responsibilities under the Treaty, it is pivotal that Māori, in partnership 
with the Crown, participate meaningfully in any policy or legislation that would shape the context of 
biobanking and genetic research for Māori in a way that augments potential benefits while 
controlling the level of risk and giving protection to taonga.  The Treaty can be viewed as “the 
founding document of New Zealand” (McDowell & Webb, 2006) and “a constitutional document” 
(Palmer, 2002), that many Māori see as “the most important document in New Zealand’s history” 
(Cooke, 1990).  It provides principles that include protection, partnership, and participation; 
however, there is no reference to the Treaty or the principles of the Treaty either within the Privacy 
Act (1993) or the Health Information Privacy Code (1993).  There is also insufficient provision to 
adequately support and promote Māori approaches within the decision-making around these issues.   
The Treaty clearly recognises the right of self-determination or tinorangatiratanga for Māori.9 
Kaitiakitanga (a way of managing the environment) is inherently linked to rangatiratanga (the right 
to exercise authority, autonomy, self-determination, self-management, and ownership) and rights of 
action over those taonga as they are used in genetic research (Treaty of Waitangi, 1840).  In this way, 
Māori should be involved in the governance and regulation of biobanks and in the development of 
ethical standards for research and biobanking practices.  This concept has been increasingly brought 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
9 See the Māori text that enables continuing rangatiratanga of Māori tribes over their possessions and taonga 
and asserts that the Crown would protect that rangatiratanga. This includes the right of self-determination 
and the right of development. The Crown receives the right to govern, a delegated power, subject to 
continuing Māori authority. 
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into New Zealand public policy on trusteeship or guardianship, especially in relation to 
environmental and resource controls under the Resource Management Act (1991, see section 7A). 
While it has been acknowledged that Māori have an individual right to participate in biobanking and 
genetic research, the collective may assert its authority to protect their whakapapa as a taonga under 
Article 2 of Te Tiriti o Waitangi (Henagan, 2006).  By paying regard to the benefits that could be 
associated with biobanking, this hurdle could be surmounted through creating a practical balance 
between the rights of the individual and those of the collective. 
The United Nations (2008) Declaration on the Rights of Indigenous Peoples confirms the right of 
Māori to maintain control and protect their genetic resources.  Article 31 provides: 
1.  Indigenous peoples have the right to maintain, control, protect and develop their cultural 
heritage, traditional knowledge and traditional cultural expressions, as well as the 
manifestations of their sciences, technologies and cultures, including human and genetic 
resources, seeds, medicines, knowledge of the properties of fauna and flora, oral traditions, 
literatures, designs, sports and traditional games and visual and performing arts.  They also 
have the right to maintain, control, protect and develop their intellectual property over such 
cultural heritage, traditional knowledge, and traditional cultural expressions. 
2.  In conjunction with indigenous peoples, States shall take effective measures to recognize 
and protect the exercise of these rights.  (p.11) 
Intellectual property is also of relevance to the protection of Māori interests in biobanking and 
genetic research.  The World Intellectual Property Organization (WIPO) is the global forum for 
intellectual property services, policy, information, and cooperation.  The WIPO Inter Governmental 
Committee (IGC) was established by the WIPO General Assembly in 2000 to provide a forum for 
States to discuss intellectual property issues in relation to traditional knowledge (TK), genetic 
resources (GRs), and traditional cultural expressions (TCEs or "expressions of folklore").  In 2009, 
the WIPO General Assembly authorized the IGC to undertake negotiations with the intention of 
reaching an agreement on the text of an international instrument to protect traditional knowledge, 
genetic resources, and traditional cultural expressions.  The WIPO IGC is currently drafting three 
texts to encapsulate and control the use and dissemination of TK, GRs and TCEs.   If the text on 
GRs is ratified, by the General Assembly of States, this could potentially become binding on New 
Zealand and provide further protection for Māori (WIPO IGC, n.d.).    
In summary, Te Tiriti o Waitangi and the United Nations Declaration on the Rights of Indigenous 
Peoples provide clear support for Māori, as Indigenous people, to govern their own process of 
collection, storage, and use of genetic material.  Whether Māori participate in existing biobanks in 
New Zealand or seek to govern their own, it is important for Māori that their agency in processes 
that affect them is enhanced, in order to achieve population-level health outcomes (Fullerton, Knerr, 
& Burke, 2012). 
Moving Forward 
There are a number of steps Māori could take to protect individual participants and communities 
participating in biobanking and genetic research.  Based on the “gaps” in the framework of current 
legislation, policy, and practice in New Zealand, a number of practical recommendations of 
10
The International Indigenous Policy Journal, Vol. 6, Iss. 3 [2015], Art. 1
http://ir.lib.uwo.ca/iipj/vol6/iss3/1
	  
international relevance are suggested to afford protection to Māori who choose to engage in 
biobanking and genetic research. 
1. Engage Māori, the medical, and the scientific community and government agencies to 
inform the development of cultural guidelines for biobanking and genetic research in 
New Zealand and elsewhere to ensure culturally safe interactions with participants and 
communities can occur. 
2. Make educational resources available to researchers about how to effectively partner 
with Māori communities covering information about Indigenous knowledge, ethics, 
research policies and protocols, and negotiation of research relationships and priorities 
with communities.  This information could be available on a website for the scientific 
community at a national and international level. 
3. Support Māori communities to develop their own research strategy; criteria for the 
assessment and evaluation of research proposals; and formal guidelines for research that 
is undertaken with them, which could include restrictions on the future use of 
biospecimens collected for specific research projects.   
4. Provide “toolkits” for Māori, available collectively and individually, about biobanking 
and genetic research including frequently asked questions, common concerns regarding 
data sharing, and strategies for addressing these concerns.  Sample consent forms and 
research agreements and contracts should also be made available to communities.   
5. Communities may consider applying penalties (for example, rejection of future research 
requests with Māori communities) if researchers conduct unapproved research or 
violate other agreed terms for conducting research.  This notion could be extended to 
ethics review and research funding mechanisms. 
6. Promote forums for Māori communities to share best practice examples of how 
communities are already participating in genetic research and biobanking to effectively 
build capacity and to ensure Māori interests are better protected. 
Moving forward, “next-generation” regulation that provides more cohesive policies and legislation 
will be needed to inform the development of national and international systems equipped to deal 
with the challenges of biobanking and associated large-scale, population-level genomic research.  
Beyond continued engagement in the ethics review process, accompanying sustainable mechanisms 
that enable Māori participation in policy development and build trust, support and effective research 
partnerships between Māori communities and researchers must be established and sustained.  A 
strong commitment to education that bridges cultural and communication differences and builds 
the capability of all stakeholders will be required. 
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Appendix 
Summary of  Legislation,  Policy and Ethical  Protection in Biobanking and Research 
Māori  
• Te Tiriti o Waitangi (the Treaty of Waitangi) (1840) 
• United Nations Declaration on the Rights of Indigenous Peoples (2008) 
• Guidelines for Researchers on Health Research Involving Māori (2008) 
Guidelines for  Research with Māori  
• Health Research Council New Zealand Guidelines for Researchers on Health Research 
Involving Māori (2008) 
• Te Ara Tika: Guidelines for Māori Research Ethics—A Framework for Researchers and 
Ethics Committee Members (2010) 
Privacy 
• Privacy Act (1993) 
• Health Information Privacy Code (1994) 
Informed Consent 
• Health and Disability Commissioner Act (1994) 
• Code of Health and Disability Services Consumers’ Rights (1996) 
Ethical  Approval  for  Research 
• New Zealand Public Health and Disability Act (2000) 
• Operational Standard for Ethics Committees (2006) 
• National Ethics Advisory Committee Ethical Guidelines for Observational Studies 
(2012a) 
• National Ethics Advisory Committee Ethical Guidelines for Intervention Studies 
(2012b) 
Biobanking and Research 
• Health Act (1956) 
• Human Tissue Act (2008)   
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• Guidelines on the Use of Human Tissue for Future Unspecified Research Purposes 
(2007) 
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